What information should be told to the doctor before taking Advagraf 0.5mg capsule?

Inform the doctor if you are allergic to the ingredient present in the Advagraf 0.5mg capsule, in case of high sugar level, pregnant or breastfeeding, or weakened immune system. Patient with medical history or medication.

Precautions that must be taken before taking Advagraf 0.5mg Capsule?

As the capsule suppresses the immune system so the risk of infection increases. Advagraf 0.5mg Capsule can increase the risk of getting cancer, such as lymph gland cancer (lymphoma) and skin cancer. It can lower the body's ability to fight infections.

Advagraf 0.5mg Capsule is an antibiotic?

Yes, Advagraf 0.5mg Capsule comes under the class macrolides, which is an antibiotic group of medicines. It is used after organ transplantation and helps prevent organ rejection after a heart, kidney, or liver transplant.

Can I drink alcohol while taking the Advagraf 0.5mg Capsule?

It is advised not to take alcohol while taking the Advagraf 0.5mg Capsule, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.

I forgot to take the Advagraf 0.5mg Capsule. What to do?

As soon as you remember, take the missed dose unless it's time for your next dose. You should never take a double dose to make up for a missed one

What are the side effects of the Advagraf 0.5mg Capsule?

Common side effects of the Advagraf 0.5mg Capsule are constipation, muscle pain, swelling, nausea, diarrhea, infection, loss of appetite, hair loss, vomiting, and weakness.

How long does the treatment with Advagraf 0.5mg Capsule last?

The doctor decides how long the treatment with the Advagraf 0.5mg Capsule will continue, depending on the stage and health of the patient.

Is it safe to take this Advagraf 0.5mg Capsule during pregnancy or breastfeeding?

During pregnancy, it is not safe to take the Advagraf 0.5mg Capsule, as it can cause harm to the unborn baby. Also, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

Advagraf 0.5mg Capsule

Name: Advagraf 0.5mg Capsule
Brand: Advagraf
Price: 400 INR
Availability: InStock
Rating: 4.86 (7 reviews)

Rx Required

Salt Composition: Tacrolimus

Expiry Date: 01/2028

Price on Request

Inclusive of all taxes

▼

10 Capsules in Strip

About The Product

Organ Transplant

Advagraf 0.5mg Capsule is medicine that is given after transplant, to safe the body from rejecting a new organ (heart, liver or kidney). This class of medicine belongs to immunosuppressants, it functions by weakening the immune system, so that it does not attack the new organs of the body.

Side Effects

Undesired symptoms or responses vary from person to person as the human body reacts differently to the Advagraf 0.5mg Capsule, but they typically resolve naturally within a few days as the body adjusts to the medicine, requiring no medical attention.
In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
Some of the common side effects of the Advagraf 0.5mg Capsule are: Fatigue Headache, infection Fever Loss of appetite High blood pressure lack of sleep Indigestion Nausea diarrhea, or constipation, kidney damage

Safety Advice

Alcohol

Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Advagraf 0.5mg Capsule, as per the research.

Pregnancy

The Advagraf 0.5 mg Capsule should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. Advagraf 0.5mg Capsule can be injected in case of severe, life-threatening conditions. However, it may harm the unborn.

Breast Feeding

The Advagraf 0.5mg Capsule is considered unsafe to be taken while breastfeeding, as there is a chance that it may pass to the developing baby through the breast milk of the mother. It is generally considered unsafe, and there is no clear evidence found in the clinical data of how it harms the baby.

Driving

Driving after taking the Advagraf 0.5mg Capsule affect or interfere with driving ability or disturb while operating machinery. Fever or dizziness, neurological effects can be seen after taking the capsule, avoid driving until you feel better.

Kidney

The Advagraf 0.5mg Capsule is considered unsafe for people with kidney problems. It can damage the kidneys. Tacrolimus, present in the capsule, is nephrotoxic.

Liver

The Advagraf 0.5mg Capsule is generally considered unsafe for people with mild to moderate liver disease. Although regular monitoring of the enzyme is required. The dose should be adjusted; take it with caution.

FAQs

Advagraf 0.5mg Capsule is used to suppress the body's immune system. It is an immunosuppressant that helps the body to accept the new organ after transplant (heart, liver, and kidney).

Advagraf 0.5mg Capsule consists of tacrolimus that binds to FKBP-12, and it inhibits calcineurin and IL-2 production, and as a result immune response is suppressed.

Reference

Hougardy, J. M., Broeders, N., Kianda, M., Massart, A., Madhoun, P., Le Moine, A., ... & Abramowicz, D.

(2011). Conversion from Prograf to Advagraf among kidney transplant recipients results in a sustained decrease in tacrolimus exposure.

Transplantation, 91(5), 566-569. Inker, L.

A., Astor, B. C., Fox, C.

H., Isakova, T., Lash, J. P., Peralta, C.

A., ... & Feldman, H. I.

(2014). KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

American Journal of Kidney Diseases, 63(5), 713-735. Manjunatha, T.

A., Chng, R., & Yau, W. P.

(2021). Efficacy and safety of tacrolimus-based maintenance regimens in de novo kidney transplant recipients: a systematic review and network meta-analysis of randomized controlled trials.

Annals of Transplantation, 26, e933588-1. Staatz, C.

E., & Tett, S. E.

(2015). Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients.

Clinical pharmacokinetics, 54(10), 993-1025. Yang, S.

S., Choi, J. Y., Cho, W.

T., Park, J. B., & Kim, S.

J. (2015, April).

A single-center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). In Transplantation Proceedings (Vol.

47, No. 3, pp.

617-621). Elsevier.

Last updated: 5 Aug 2026 | 04:33 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions